Skip to content

Effect of Electromagnetic Therapy on Patients With Chronic Rhinosinusitis.

CompletedNot applicableNCT05865613
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

This study aimed to evaluate the efficacy of Pulsed electromagnetic field (PEMF) for Chronic sinusitis in a randomized, double-blind, placebo-controlled trial.

Study details

Official title
Effect of Pulsed Electromagnetic Field Therapy on Headache, Fatigue, and CT Finding on Patients With Chronic Rhinosinusitis.
Conditions
Interventions
  • Device: Pulsed electromagnetic field
Sponsor
Cairo University
Start date
2023-06-15
Primary completion
2024-01-11
Sex
All
Age range
from 20 Years to 40 Years
Results posted
No results posted in this snapshot
Countries
Egypt
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients suffering from mild to moderate symptoms of rhinosinusitis. Exclusion Criteria: * pregnant or breastfeeding women. * patients with definite deviated nasal septum, sinusitis, or history of operation within the last 6 months. * patients with hypertension, diabetes mellitus, malignancy, active pulmonary tuberculosis, infection, active respiratory disease like asthma, or other systemic diseases. * patients with long-term use of corticosteroids or immunosuppressive agents. * patients who were involved in another clinical study within 30 days. * patients who were unable to comply with the follow-up schedules. * patients who had used antihistamines within 1 week, topical corticosteroids within 2 weeks, systemic corticosteroids within 4 weeks, anti-cholinergic drugs within 3 days, antileukotriene drugs within 1 week, decongestants within 3 days, tricyclic antidepressants or phenothiazines within 2 weeks, non-steroidal analgesics within 2 weeks, and other drugs which the researchers believed were inappropriate.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05865613